Difference between revisions of "Insys Therapeutics"
Jump to navigation
Jump to search
(bankruptcy) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{group | {{group | ||
|wikipedia=https://en.wikipedia.org/wiki/Insys_Therapeutics | |wikipedia=https://en.wikipedia.org/wiki/Insys_Therapeutics | ||
| − | |constitutes= | + | |constitutes=Big pharma |
|logo=Insys Therapeutics.png | |logo=Insys Therapeutics.png | ||
|titular_logo=1 | |titular_logo=1 | ||
| − | |start= | + | |start=1990 |
| + | |leaders=Insys/CEO | ||
|headquarters=Chandler, Arizona | |headquarters=Chandler, Arizona | ||
|website=http://www.insysrx.com/ | |website=http://www.insysrx.com/ | ||
|founders=John Kapoor | |founders=John Kapoor | ||
| + | |description=Big pharma that promoted opioids | ||
}} | }} | ||
'''Insys Therapeutics''' is a manufacturer of [[pharmaceuticals]], most notably Subsys, a sublingual [[fentanyl]] spray which has been linked to the increase in opioid-related deaths in the USA. | '''Insys Therapeutics''' is a manufacturer of [[pharmaceuticals]], most notably Subsys, a sublingual [[fentanyl]] spray which has been linked to the increase in opioid-related deaths in the USA. | ||
| Line 15: | Line 17: | ||
==Arrest== | ==Arrest== | ||
| − | [[John Kapoor]], the founder of Insys, was arrested in October 2017, charged with racketeering and fraud in connection with "a nationwide scheme to push an extremely potent opioid drug containing [[fentanyl]] onto patients."<ref>https://arstechnica.com/tech-policy/2017/10/doj-billionaire-pharma-owner-fueled-the-opioid-epidemic-with-bribery-scheme/</ref> | + | [[John Kapoor]], the founder of Insys, was arrested in October 2017, charged with racketeering and [[fraud]] in connection with "a nationwide scheme to push an extremely potent opioid drug containing [[fentanyl]] onto patients."<ref>https://arstechnica.com/tech-policy/2017/10/doj-billionaire-pharma-owner-fueled-the-opioid-epidemic-with-bribery-scheme/</ref> |
| + | |||
| + | ==Bankruptcy== | ||
| + | In June 2019, facing over 1000 lawsuits, Insys Therapeutics declared bankruptcy.<ref>https://arstechnica.com/science/2019/06/alleged-lap-dancing-opioid-maker-may-stiff-feds-on-225m-payout-with-bankruptcy/</ref> | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Latest revision as of 07:19, 12 June 2019
 Insys Therapeutics  (Big pharma)    | |
|---|---|
 | |
| Formation | 1990 |
| Founder |  John Kapoor |
| Headquarters | Chandler, Arizona |
| Leader | Insys/CEO |
| Big pharma that promoted opioids | |
Insys Therapeutics is a manufacturer of pharmaceuticals, most notably Subsys, a sublingual fentanyl spray which has been linked to the increase in opioid-related deaths in the USA.
Activities
In 2017, the company donated $500,000 to try to defeat a ballot initiative that would make recreational use of marijuana legal under Arizona law.[1]
Arrest
John Kapoor, the founder of Insys, was arrested in October 2017, charged with racketeering and fraud in connection with "a nationwide scheme to push an extremely potent opioid drug containing fentanyl onto patients."[2]
Bankruptcy
In June 2019, facing over 1000 lawsuits, Insys Therapeutics declared bankruptcy.[3]
Related Quotation
| Page | Quote | Author | Date |
|---|---|---|---|
| Claire McCaskill | “This company has repeatedly gotten away with fines that amounted to a slap on the wrist for actions that helped fuel a nationwide epidemic that’s claimed hundreds of thousands of American lives. Anyone, including top executives, who potentially violated criminal law should be aggressively prosecuted.” | Claire McCaskill | October 2017 |
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
References
- ↑ https://www.usnews.com/news/articles/2016-09-08/fentanyl-maker-donates-big-to-campaign-opposing-pot-legalization
- ↑ https://arstechnica.com/tech-policy/2017/10/doj-billionaire-pharma-owner-fueled-the-opioid-epidemic-with-bribery-scheme/
- ↑ https://arstechnica.com/science/2019/06/alleged-lap-dancing-opioid-maker-may-stiff-feds-on-225m-payout-with-bankruptcy/
